Combined BET and MEK inhibition in SCLC cell lines resulted in synergistic growth inhibition and cytotoxicity, even in cell lines (NCI-H1092) that are completely resistant to the monotherapies (Supplemental Figure S10A-B). This evidence concerns the gene MAP2K7 and small cell lung carcinoma.